MFG
ALXN

MidWestOne Financial Group’s Alexion Pharmaceuticals ALXN Stock Holding History

MidWestOne Financial Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,127
Closed -$1.89M – 230
2020
Q4 		$1.89M Buy
12,127
+1,232
+11% +$158K 0.52% 41
2020
Q3 		$1.25M Buy
10,895
+1,548
+17% +$167K 0.41% 60
2020
Q2 		$1.05M Buy
9,347
+2,078
+29% +$221K 0.44% 41
2020
Q1 		$653K Buy
7,269
+1,537
+27% +$151K 0.24% 99
2019
Q4 		$619K Buy
5,732
+364
+7% +$38.9K 0.13% 131
2019
Q3 		$526K Buy
5,368
+371
+7% +$41.8K 0.16% 136
2019
Q2 		$655K Buy
+4,997
New +$644K 0.18% 138

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return